DECREASED EYE CONTACT

DECREASED EYE CONTACT was reported 304 times

These drug classes are most commonly taken by patients reporting DECREASED EYE CONTACT:

# Drug Count
0 Atypical Antipsychotic [EPC] 62
1 Anti-epileptic Agent [EPC] 57
2 Mood Stabilizer [EPC] 55
3 Central alpha-2 Adrenergic Agonist [EPC] 34
4 Central Nervous System Stimulant [EPC] 32
5 Corticosteroid [EPC] 26
6 Nonsteroidal Anti-inflammatory Drug [EPC] 23
7 Benzodiazepine [EPC] 22
8 Proton Pump Inhibitor [EPC] 17
9 Folate Analog Metabolic Inhibitor [EPC] 11
10 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 9
11 Nucleoside Metabolic Inhibitor [EPC] 9
12 Platinum-based Drug [EPC] 9
13 Serotonin-3 Receptor Antagonist [EPC] 9
14 Tumor Necrosis Factor Blocker [EPC] 9
15 Expectorant [EPC] 8
16 Osmotic Laxative [EPC] 8
17 Provitamin D2 Compound [EPC] 8
18 Vitamin B12 [EPC] 8
19 Vitamin C [EPC] 8
20 Vitamin D [EPC] 8
21 Dopamine-2 Receptor Antagonist [EPC] 6
22 HMG-CoA Reductase Inhibitor [EPC] 6
23 Phenothiazine [EPC] 6
24 Purine Antimetabolite [EPC] 6
25 Dihydropyridine Calcium Channel Blocker [EPC] 5
26 Calcium Channel Blocker [EPC] 4
27 Loop Diuretic [EPC] 4
28 Microtubule Inhibitor [EPC] 4
29 Typical Antipsychotic [EPC] 4
30 gamma-Aminobutyric Acid-ergic Agonist [EPC] 4
31 Cardiac Glycoside [EPC] 3
32 Histamine-1 Receptor Antagonist [EPC] 3
33 Histamine-2 Receptor Antagonist [EPC] 3
34 Leukotriene Receptor Antagonist [EPC] 3
35 Macrolide Antimicrobial [EPC] 3
36 Thiazide-like Diuretic [EPC] 3
37 beta-Adrenergic Blocker [EPC] 3
38 Aluminum Complex [EPC] 2
39 CD20-directed Cytolytic Antibody [EPC] 2
40 Estrogen [EPC] 2
41 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2
42 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2
43 Integrin Receptor Antagonist [EPC] 2
44 Leukocyte Growth Factor [EPC] 2
45 Nitroimidazole Antimicrobial [EPC] 2
46 Opioid Agonist [EPC] 2
47 Potassium Salt [EPC] 2
48 Progestin [EPC] 2
49 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 2
50 alpha-Adrenergic Blocker [EPC] 2
51 5-alpha Reductase Inhibitor [EPC] 1
52 Aldosterone Antagonist [EPC] 1
53 Alkylating Drug [EPC] 1
54 Amide Local Anesthetic [EPC] 1
55 Androgen Receptor Inhibitor [EPC] 1
56 Angiotensin Converting Enzyme Inhibitor [EPC] 1
57 Antiarrhythmic [EPC] 1
58 Aromatic Amino Acid [EPC] 1
59 Azole Antifungal [EPC] 1
60 Bile Acid [EPC] 1
61 CD19-directed Chimeric Antigen Receptor [EPC] 1
62 Carbonic Anhydrase Inhibitor [EPC] 1
63 Catecholamine [EPC] 1
64 Cephalosporin Antibacterial [EPC] 1
65 Cytochrome P450 3A Inhibitor [EPC] 1
66 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1
67 Ester Local Anesthetic [EPC] 1
68 Factor Xa Inhibitor [EPC] 1
69 Fluoroquinolone Antibacterial [EPC] 1
70 Genetically-modified Autologous T Cells [EPC] 1
71 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
72 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
73 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
74 Human Immunoglobulin G [EPC] 1
75 Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] 1
76 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 1
77 Insulin Analog [EPC] 1
78 Interferon beta [EPC] 1
79 Methylxanthine [EPC] 1
80 Nitrate Vasodilator [EPC] 1
81 Non-Standardized Chemical Allergen [EPC] 1
82 Phosphodiesterase 5 Inhibitor [EPC] 1
83 Platelet Aggregation Inhibitor [EPC] 1
84 Polyene Antifungal [EPC] 1
85 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
86 Protease Inhibitor [EPC] 1
87 RANK Ligand Inhibitor [EPC] 1
88 Sphingosine 1-phosphate Receptor Modulator [EPC] 1
89 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 1
90 Sulfonamide Antimicrobial [EPC] 1
91 Tetracycline-class Drug [EPC] 1
92 Thiazide Diuretic [EPC] 1
93 alpha-Adrenergic Agonist [EPC] 1
94 beta-Adrenergic Agonist [EPC] 1